Differential cyclooxygenase expression levels and survival associations in type I and type II ovarian tumors.

about

Differential cyclooxygenase expression levels and survival associations in type I and type II ovarian tumors.

Item

http://www.wikidata.org/entity/Q50334520

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Differential cyclooxygenase ex ...... I and type II ovarian tumors.

@en

Differential cyclooxygenase ex ...... I and type II ovarian tumors.

@nl

type

Item

label

Differential cyclooxygenase ex ...... I and type II ovarian tumors.

@en

Differential cyclooxygenase ex ...... I and type II ovarian tumors.

@nl

prefLabel

Differential cyclooxygenase ex ...... I and type II ovarian tumors.

@en

Differential cyclooxygenase ex ...... I and type II ovarian tumors.

@nl

P1476

Differential cyclooxygenase ex ...... I and type II ovarian tumors.

@en

P2093

Alicia Beeghly-Fadiel

http://www.w3.org/2001/XMLSchema#string

Andrew J Wilson

http://www.w3.org/2001/XMLSchema#string

Dineo Khabele

http://www.w3.org/2001/XMLSchema#string

Lawrence J Marnett

http://www.w3.org/2001/XMLSchema#string

Marta A Crispens

http://www.w3.org/2001/XMLSchema#string

Meral El Ramahi

http://www.w3.org/2001/XMLSchema#string

Oluwole Fadare

http://www.w3.org/2001/XMLSchema#string

Spencer Keene

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2013

Extracellular signal-regulated kinase is a target of cyclooxygenase-1-peroxisome proliferator-activated receptor-delta signaling in epithelial ovarian cancer

Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer--shifting the paradigm.

Aberrant over-expression of COX-1 intersects multiple pro-tumorigenic pathways in high-grade serous ovarian cancer

Expression of cyclooxygenase 2 is an independent prognostic factor in human ovarian carcinoma

Rethinking ovarian cancer: recommendations for improving outcomes.

Cyclooxygenase-1 is a potential target for prevention and treatment of ovarian epithelial cancer

Automated Quantitative Analysis of p53, Cyclin D1, Ki67 and pERK Expression in Breast Carcinoma Does Not Differ from Expert Pathologist Scoring and Correlates with Clinico-Pathological Characteristics.

Ovarian Cancer Risk Factors by Histologic Subtype: An Analysis From the Ovarian Cancer Cohort Consortium.

Cyclooxygenase-2 in oncogenesis.

P2888

s13048-018-0389-9

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13048-018-0389-9

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Shu Xu

P577

2018-02-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1101228994

http://www.w3.org/2001/XMLSchema#string

P698

29482584

http://www.w3.org/2001/XMLSchema#string

P932

5828488

http://www.w3.org/2001/XMLSchema#string